While in mild COVID-19, AlvMφ upregulate phagocytosis-related pathways and IFN signaling, AlvMφ from severely diseased patients display increased IL-10 expression, thus inhibiting antiviral IFN responses [205]. The gene discussed is IFNA1; the disease is COVID-19.